AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
DESITIN has 0.3 points more BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: DESITIN (desitin.com)
DESITIN provides high technical substance regarding its product composition but fails the digital transparency test. It is a high-substance brand trapped in a trust-theatre shell, providing all the data necessary for a pharmaceutical product but none of the external proof paths modern users expect.
Implement JSON-LD Product and Organization schema immediately to anchor digital identity. Replace the asterisk-based clinical claims with direct hyperlinks to the relevant peer-reviewed studies or clinical trial registrations. Add a For Healthcare Professionals section with downloadable data sheets and published study abstracts. Include named medical advisors with links to their professional credentials to bridge the expert authority gap.
The site exhibits high substance in its body text, specifically on the Daily Defense Cream page which lists 13% Zinc Oxide, storage ranges of 20 to 25 C, and a 12-hour relief window. Heading fluff is moderate, with phrases like A Tube for Every Tush and Make a Play for Prevention, but these are immediately grounded by specific product mentions. The body substance ratio is high due to the presence of 17 distinct inactive ingredients and technical directions for use.
If your @id chain is broken, your entire knowledge graph collapses into isolated nodes. Check your AI visible entity graph with a free one page structured data interpretation.
There is zero detectable semantic drift between the homepage and sub-pages. The H1 promise on the homepage (Everything You Need to Know About Baby Diaper Rash) is directly fulfilled by the Identifying Diaper Rash and Diaper Rash Products sub-pages. The messaging remains consistent, focusing on prevention and treatment across all slots.
Move beyond vague agency reporting and visualize your surgical implementation plan. Order an Executive SEO Strategy and stop relying on superficial keyword tracking.
Trust theatre is present as both the homepage and product pages show a review_count (up to 24) with a proof_links_count of 0, meaning reviews are hosted internally without third-party verification. The claim #1 Choice of Pediatricians is qualified with an asterisk but lacks a direct link to the study or survey data. The clinical evidence section mentions 90% of babies had relief but provides no citation to a peer-reviewed journal.
The ratio of verifiable technical evidence (ingredients, drug facts) to vague assertions is high. However, the ratio of internal claims to external proof paths is 0.0, as there are no outbound links to case studies, publications, or certifications. The specific count of 13% Zinc Oxide provides more substance than typical consumer marketing, but it remains unverified by third-party links.
To evaluate URL identity stability and multilingual coherence, review the Yoast Identity Stability audit. View the Yoast Identity Stability Audit for a practical example of canonical alignment and language layer integrity.
The site relies on standard industry cliches such as dermatologist-tested, hypoallergenic, and pediatrician tested. Template language like Sort by, Our products, and Email Signup are present but offset by specific technical content like the frosting a cake application analogy. The value proposition is somewhat commoditized, as the active ingredient (Zinc Oxide) is a standard pharmaceutical staple.
A significant authority gap exists due to the total absence of schema_json across all crawled pages, which is unexpected for a major pharmaceutical brand. No individual medical experts or authors are named to back the expert-level care claims, relying instead on the brand name as the sole authority. The lack of Person schema or sameAs links to medical professionals further widens this gap.
The marketing tone makes bold claims like comfort restored and relief from the first use, which are technically supported by internal study mentions but lack external validation. While the product specs are detailed, the lack of an outbound link to the actual clinical trial data creates a disconnect for an evidence-based medical product. The #1 Choice claim is a classic performance claim without a visible primary source.
Medical Devices, Pharma & Biotech BS: DESITIN (desitin.com)
The site strongly aligns with the Pharmaceutical and Medical Device industry by focusing on active ingredients like 13% Zinc Oxide and clinical efficacy. The content structure mimics a drug facts label, emphasizing dosage, storage, and safety warnings.
Every retrieval error rooted in "wrong page surfaced" begins with one failure: unstable URL identity. Read the URL & Canonical Technical Guide to learn how consistent paths and canonical alignment preserve semantic cohesion.
“The moderate BS score of 41 is primarily driven by technical authority gaps (missing schema) and trust theatre (reviews without proof paths). The site avoided a higher score due to its high density of technical specifications and perfect semantic alignment between pages. The lack of external validation is the primary anchor preventing a lower score.”
Analysis Disclosure & Source Attribution
Snapshot Date: May 29, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at DESITIN to view the most current version of their content and see directly what the company offers.